wayground logo

Free Printable Worksheets

Font size

S
M
L
XL
Worksheets

Manage dyslipidemia in primary prevention

Total questions: 17

Worksheet time: 17mins

Name
Class
Date
1.

How confident are you in treating dyslipidemia?

Please express it on a scale of 1-5, with 5 representing full confidence.

a)

1

b)

2

c)

3

d)

4

e)

5

2.

Base on ATP III guideline, a man aged 55 years, smoker, non-diabetes, no known ASCVD or other risk factors. BP 120/80mmHg. LDL 2.8mmol/L, HDL 1.3mmol/L. 10 years CHD risk 13%. Which is his ideal LDL target?

a)

<1.8mmol/L

b)

<2.6mmol/L

c)

<3.4mmol/L

d)

<4.2mmol/L

3.

Base on USPSTF recommendation, a man aged 55 years, smoker, non-diabetes, no known ASCVD or other risk factors. BP 120/80mmHg. LDL 2.8mmol/L, HDL 1.3mmol/L. 10 years ASCVD risk 11%. What is the appropriate treatment for him?

a)

Life modification only

b)

Low intensity statin

c)

Moderate intensity statin

d)

High intensity statin

4.

Base on ACC/AHA guideline, a man aged 55 years, smoker, diabetes, no known ASCVD or other risk factors. BP 120/80mmHg. LDL 2.8mmol/L, HDL 1.3mmol/L. 10 years ASCVD risk 20%. What is the appropriate treatment for him?

a)

Life modification only

b)

Low intensity statin

c)

Moderate intensity statin

d)

High intensity statin

5.

Which is the correct term?

a)

血脂

b)

膽固醇

6.

Which guideline is suitable for our primary care setting?

a)

ATP III

b)

USPSTF

c)

ACC/AHA

d)

ESC/ECA

e)

中國成人血脂異常防治指引

7.

Which guideline is using in your daily practice?

a)

ATP III

b)

中國成人血脂異常防治指引

c)

ACC/AHA

d)

ESC/EAC

e)

USPSTF

8.

Based on ACC/AHA guideline, a male patient aged 40 years, with T2DM. His LDL is 3mmol/L, no other risk factor . What kind of treatment is suitable for him?

a)

Life style modification only

b)

High intensity statin

c)

Moderate intensity statin

d)

Low intensity statin

9.

Based on ACC/AHA guideline, a male patient aged 50 years, smoker, with T2DM for 10 years. His LDL is 3mmol/L. What kind of treatment is suitable for him?

a)

life style modification only

b)

High intensity statin

c)

Moderate intensity statin

d)

Low intensity statin

10.

Based on ACC/AHA guideline, a male patient aged 70 years, no ASCVD or other risk factor. 10 years ASCVD risk 20.4%. His LDL is 3mmol/L. What kind of treatment is suitable for him?

a)

life style modification only

b)

High intensity statin

c)

Moderate intensity statin

d)

Low intensity statin

11.

Based on USPSTF, a male patient aged 40 years, with T2DM. His LDL is 3mmol/L, no other risk factor, 10 years ASCVD risk 2.0% . What kind of treatment is suitable for him?

a)

Life style modification only

b)

High intensity statin

c)

Moderate intensity statin

d)

Low intensity statin

12.

Based on USPSTF, a male patient aged 50 years, smoker, with T2DM for 10 years. His LDL is 3mmol/L. 10 years ASCVD risk 13.8%. What kind of treatment is suitable for him?

a)

life style modification only

b)

High intensity statin

c)

Moderate intensity statin

d)

Low intensity statin

13.

Based on USPSTF recommendations, a male patient aged 70 years, no ASCVD or other risk factor. 10 years ASCVD risk 18.1%. His LDL is 3mmol/L. What kind of treatment is suitable for him?

a)

life style modification only

b)

High intensity statin

c)

Moderate intensity statin

d)

Low intensity statin

14.

Based on ATP III, a male patient aged 40 years, with T2DM. His LDL is 3mmol/L, no other risk factor. What is the LDL target in this case?

a)

<1.8mmol/L

b)

<2.6mmol/L

c)

<3.4mmol/L

d)

<4.2mmol/L

e)

<4.9mmol/L

15.

Based on ATP III, a male patient aged 50 years, smoker, with T2DM for 10 years. His LDL is 3mmol/L. 10 years CHD risk 24.3%. Which LDL target is suitable for this case?

a)

<1.8mmol/L

b)

<2.6mmol/L

c)

<3.4mmol/L

d)

<4.2mmol/L

e)

<4.9mmol/L

16.

Based on ATP III guideline, a male patient aged 70 years, no ASCVD or other risk factor. 10 years CHD risk 20.7%. His LDL is 3mmol/L. What kind of treatment is suitable for him?

a)

<1.8mmol/L

b)

<2.6mmol/L

c)

<3.4mmol/L

d)

<4.2mmol/L

e)

<4.9mmol/L

17.

After finishing this lecture, which guideline do you think is suitable for our primary care setting?

a)

ATP III

b)

USPSTF

c)

ACC/AHA

d)

ESC/ECA

e)

中國成人血脂異常防治指引